The role of macrophage migration inhibitory factor in autoimmune liver disease

Hepatology

Volumn 59, Issue 2, 2014, Pages 580-591

  Assis, David N ^a   Leng, Lin ^a   Du, Xin ^a   Zhang, Clarence K ^b   Grieb, Gerrit ^a,c   Merk, Melanie ^a   Garcia, Alvaro Baeza ^a   Mccrann, Catherine ^a   Chapiro, Julius ^a,d   Meinhardt, Andreas ^d   Mizue, Yuka ^e   Nikolic Paterson, David J ^f   Bernhagen, Jürgen ^c   Kaplan, Marshall M ^g   Zhao, Hongyu ^b   Boyer, James L ^a   Bucala, Richard ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e Sapporo Immunodiagnostic Laboratory   (Japan)

^f MONASH UNIVERSITY   (Australia)

^g TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD74 ANTIGEN; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; AGED; ALLELE; ARTICLE; AUTOIMMUNE HEPATITIS; CAUCASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STELLATE CELL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENE FREQUENCY; HEPATITIS, AUTOIMMUNE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIVER; LIVER CIRRHOSIS, BILIARY; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84893656137     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26664     Document Type: Article

References (44)

1. Grieb G, Merk M, Bernhagen J, Bucala R. Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect 2010;23:257-264.
2. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003;3:791-800.
3. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68-71.
4. Flaster H, Bernhagen J, Calandra T, Bucala R. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Mol Endocrinol 2007;21:1267-1280.
5. Radstake TR, Sweep FC, Welsing P, Franke B, Vermeulen SH, Geurts-Moespot A, et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005;52:3020-3029.
6. Wu SP, Leng L, Feng Z, Liu N, Zhao H, McDonald C, et al. Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma. Arthritis Rheum 2006;54:3661-3669.
7. Murakami H, Akbar SM, Matsui H, Onji M. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest 2001;31:337-343.
8. Nohara H, Okayama N, Inoue N, Koike Y, Fujimura K, Suehiro Y, et al. Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol 2004;39:242-246.
9. Sreih A, Ezzeddine R, Leng L, LaChance A, Yu G, Mizue Y, et al. Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus. Arthritis Rheum 2011;63:3942-3951.
10. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
11. Bonder A, Retana A, Winston DM, Leung J, Kaplan MM. Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol 2011;9:609-612.
12. Fingerle-Rowson G, Koch P, Bikoff R, Lin X, Metz CN, Dhabhar FS, et al. Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. Am J Pathol 2003;162:47-56.
13. Shi X, Leng L, Wang T, Wang W, Du X, Li J, et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 2006;25:595-606.
14. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, et al. MIF signal transduction initiated by binding to CD74. J Exp Med 2003;197:1467-1476.
15. Zhao JH. 2LD, GENECOUNTING and HAP: computer programs for linkage disequlibrium analysis. Bioinformatics 2004;20:1325-1326.
16. Wigginton JE, Abecasis GR. PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 2005;21:3445-3447.
17. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006;354:54-66.
18. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005;353:1261-1273. [Erratum in N Engl J Med 2006;354:313.]
19. Zhang HY, Nanji AA, Luk JM, Huang XR, Lo CM, Chen YX, et al. Macrophage migration inhibitor factor expression correlates with inflammatory changes in human chronic hepatitis B infection. Liver Int 2005;25:571-579.
20. Zhong XB, Leng L, Beitin A, Chen R, McDonald C, Hsiao B, et al. Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies. Nucleic Acids Res 2005;33:e121.
21. Yende S, Angus DC, Kong L, Kellum JA, Weissfeld L, Ferrell R, et al. The influence of macrophage migration inhibitory factor gene polymorphism on outcome from community-acquired pneumonia. FASEB J 2009;23:2403-2411.
22. Levine SJ. Molecular mechanisms of soluble cytokine receptor generation. J Biol Chem 2008;283:14177-14181.
23. Borghese F, Clanchy FI. CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease. Expert Opin Ther Targets 2011;15:237-251.
24. Matza D, Kerem A, Medvedovsky H, Lantner F, Shachar I. Invariant chain-induced B cell differentiation requires intramembrane proteolytic release of the cytosolic domain. Immunity 2002;17:549-560.
25. Becker-Hermam S, Arie G, Medvedovsky H, Kerem A, Shachar I. CD74 is a member of the regulated intramembrane proteolysis-processed protein family. Mol Biol Cell 2005;16:5061-5069.
26. Maubach G, Lim MC, Kumar S, Zhuo L. Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment. Biochim Biophys Acta 2007;1773:219-231.
27. Vergani D, Mieli-Vergani G. Aetiopathogenesis of autoimmune heaptitis. World J Gastroenterol 2008;14:3306-3312.
28. Heinrichs D, Knauel M, Offermanns C, Berres ML, Nellen A, Leng L, et al. Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74. Proc Natl Acad Sci USA 2011;108:17444-17449.
29. Sun HW, Bernhagen J, Bucala R, Lolis E. Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A 1996;93:5191-5196.
30. Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996;93:7849-7854.
31. Kim HR, Park MK, Cho ML, Yoon CH, Lee SH, Park SH, et al. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis. J Rheumatol 2007;34:927-936.
32. Foote A, Briganti EM, Kipen Y, Santos L, Leech M, Morand EF. Macrophage migration inhibitory factor in systemic lupus erythematosus. J Rheumatol 2004;31:268-273.
33. Doherty DG, Donaldson PT, Underhill JA, Farrant JM, Duthie A, Mieli-Vergani G, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 1994;19:609-615.
34. Strettell MD, Donaldson PT, Thomson LJ, Santrach PJ, Moore SB, Czaja AJ, et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 1997;112:2028-2035.
35. Gregory WL, Mehal W, Dunn AN, Cavanagh G, Chapman R, Fleming KA, et al. Primary biliary cirrhosis: contribution of HLA class II allele DR8. Q J Med 1993;86:393-399.
36. Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y, et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. New Engl J Med 2009;360:2544-2555. [Erratum in N Engl J Med 2009;360:2797-2798.]
37. Agarwal K, Czaja AJ, Jones DE, Donaldson PT. Cytotoxic T lymphocyte-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 2000;31:49-53.
38. Fan LY, Tu XQ, Cheng QB, Zhu Y, Feltens R, Pfeiffer T, et al. Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population. World J Gastroenterol 2004;10:3056-3059.
39. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 2007;13:587-596.
40. Arunachalam B, Lamb CA, Cresswell P. Transport properties of free and MHC class Il-associated oligomers containing different isoforms of human invariant chain. Int Immunol 1994:6:439-451.
41. Bevec T, Stoka K, Pungercic G, Dolenc I, Turk V. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J Exp Med 1996;183:1331-1338.
42. Eynon EE, Schlax C, Pieters J. A secreted form of the major histocompatibility complex class II-associated invariant chain inhibiting T cell activation. J Biol Chem 1999;274:26266-26271.
43. Fingerle-Rowson G, Kaleswarapu DR, Schlander C, Kabgani N, Brocks T, Reinart N, et al. A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation. Mol Cell Biol 2009;29:1922-1932.
44. Merk M, Zierow S, Leng L, Das R, Du X, Schulte W, et al. The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF). Proc Nat Acad Sci USA 2011;108:E577-E585.